CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Shares withheld for taxes SVP & CFO gave up 6,210 shares (to pay taxes)
- 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 3,653 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT & CEO gave up 17,455 shares (to pay taxes)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $66.54 ($16,635)
- 4 Planned sale SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $65.81 ($1,316,200)
- 8-K Event Results of operations · Regulation FD disclosure
- 144 Insider Sale of Securities
- 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 10,000 shares at $67.17 ($671,700)
- 4 Open-market sale SVP & CFO sold 7,787 shares at $65.55 ($510,438)
- 4 Open-market sale PRESIDENT & CEO sold 45,257 shares at an average $66.10 ($2,991,469)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale SVP OPS & PROD DEV sold 24,338 shares at $66.37 ($1,615,313)
- 4 Shares withheld for taxes SVP, GENERICS gave up 2,494 shares (to pay taxes)
- 4 Shares withheld for taxes HEAD OF RARE DISEASE gave up 2,110 shares (to pay taxes)
- 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 40,000 shares at an average $65.77 ($2,630,864)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 17 of 90 · 1,784 filings